Trial intelligence / Profile preview

MOSST Study: Steroid Pulse Therapy for SJS/TEN

jRCTs061180044Completed

Sponsor
Ministry of Health, Labour and Welfare
Start
Jun 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Open-label, single-arm trial of methylprednisolone in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), sponsored by Ministry of Health, Labour and Welfare. Started Jun 2017; status: completed.

02

Drugs

methylprednisolone
03

Conditions

Stevens-Johnson syndrome (SJS)toxic epidermal necrolysis (TEN)

Beyond the preview

Go deeper on jRCTs061180044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061180044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call